IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vestal Point Capital, LP

Q4 2025 Holdings

Filed 2026-02-17 | 76 holdings | $2.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$37.3M175,0001.3%
Axsome Therapeutics Inc(AXSM)COM05464T104$38.4M210,0001.3%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$41.3M1,650,0001.4%
Apogee Therapeutics Inc(APGE)COM03770N101$41.5M550,0001.4%
Alto Neuroscience Inc(ANRO)COM SHS02157Q109$44.2M2,485,0001.5%
Lexeo Therapeutics Inc(LXEO)COM52886X107$44.4M4,475,0001.5%
Day One Biopharmaceuticals Inc(DAWN)COM23954D109$48.5M5,200,0001.6%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$49.3M290,0001.7%
Disc Medicine Inc(IRON)COM254604101$58.4M735,0002.0%
Enliven Therapeutics Inc(ELVN)COM29337E102$59.0M3,830,0002.0%
Arrowhead Pharmaceuticals Inc(ARWR)COM04280A100$59.8M900,0002.0%
Bicara Therapeutics Inc(BCAX)COM055477103$60.2M3,575,0002.0%
Tyra Biosciences Inc(TYRA)COM90240B106$63.8M2,425,0002.2%
Immatics NV(IMTX)SHSN44445109$64.3M6,125,0002.2%
Abbott Laboratories(ABT)COM002824100$75.2M600,0002.6%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$75.6M13,750,0002.6%
Merck & Co Inc(MRK)COM58933Y105$81.6M775,0002.8%
Dexcom Inc(DXCM)COM252131107$84.6M1,275,0002.9%
Alcon AG(ALC)ORD SHSH01301128$87.1M1,105,0003.0%
Nurix Therapeutics Inc(NRIX)COM67080M103$89.0M4,690,0003.0%
Globus Medical Inc(GMED)CL A379577208$111.3M1,275,0003.8%
BioMarin Pharmaceutical Inc(BMRN)COM09061G101$178.3M3,000,0006.1%
Terns Pharmaceuticals Inc(TERN)COM880881107$181.8M4,500,0006.2%
Arcellx Inc(ACLX)COMMON STOCK03940C100$190.7M2,925,0006.5%
Invesco QQQ Trust Series 1(QQQ)PutUNIT SER 146090E103$215.0M350,0007.3%
Abivax SA(ABVX)SPONSORED ADS00370M103$256.2M1,900,0008.7%
PreviousPage 2 of 2